Spots Global Cancer Trial Database for Prescription of Letrozole for Uterine Myoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prescription of Letrozole for Uterine Myoma
Official Title: Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial
Study ID: NCT06143631
Study Description
Brief Summary: The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
Detailed Description:
Keywords
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
University of California, Sans Francisco, San Francisco, California, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Contact Details
Name: Vanessa Jacoby, MD, MAS
Affiliation: University of California, San Francisco
Role: PRINCIPAL_INVESTIGATOR
Name: Alison Huang, MD, MAS
Affiliation: University of California, San Francisco
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
